Karachi: Pakistan Stock Exchange Limited is set to welcome BF Biosciences Limited (BFBL) to its Main Board, with trading beginning on October 21, 2024. The company, known by its security code "FBIO", will see its shares start at a price of PKR 77 per share.

The initiation of trading follows the company’s shares being declared an eligible security by the Central Depository Company of Pakistan Limited (CDC). According to information available from the Pakistan Stock Exchange (PSX), the first settlement date is scheduled for October 23, 2024, with all transactions to be settled on a T+2 basis. This listing allows BF Biosciences, noted for its role in the pharmaceuticals sector, to enhance its visibility and access to capital through public investment.

Each share is priced at PKR 3, establishing a minimal market lot for investors. The listing not only represents a significant milestone for BF Biosciences but also underscores the pharmaceutical sector's growing influence within the PSX’s daily trading activities.

Share registrar services for BFBL are managed by CDC Share Registrar Services Limited, located in Shahrah Faisal, Karachi. The registrar's role will facilitate the smooth processing of transactions and investor inquiries post-listing.

The company’s entrance into the stock market is seen as a strategic move to tap into a broader investor base and fuel its future expansion plans. This development is expected to attract considerable attention from investors interested in the pharmaceuticals industry, adding to the sector's representation on the national stock exchange.